Structural basis for substrate selectivity by site-one protease revealed by studies with a small-molecule inhibitor
Open Access
- 29 April 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (18)
Abstract
Site-one protease (S1P) carries out the first proteolytic step to activate membrane-bound effector proteins in the Golgi. S1P matures through an autocatalytic process that begins in the endoplasmic reticulum (ER) and culminates with the displacement of its inhibitory pro-domain by its cofactor, sterol regulatory element binding protein-regulating gene (SPRING). Spatial control of S1P activity and substrate localization underpins signaling pathways governing, among others, lipogenesis, ER stress, and lysosome biogenesis. The factors governing these pathways are activated by S1P-mediated proteolysis upon their regulated transport from the ER to the Golgi. S1P cleaves substrates with the recognition sequence RX(L/I/V)Z, where X is any residue other than Cys or Pro and Z is preferably Leu or Lys. However, the structural basis for substrate recognition by S1P has remained unknown. Here, we used the small molecule PF-429242, a competitive inhibitor of S1P, to investigate substrate recognition by the S1P/SPRING complex. We determined the structure of S1P/SPRING bound to PF-429242 and found that PF-429242 binds S1P in the same pocket that recognizes the substrate’s conserved P 4 Arg. Further structural analysis suggests that S1P requires a conformation change to accommodate the substrate’s P 2 (L/I/V) residue. We designed an S1P mutation (I308A) to reduce the steric clash at the P 2 position and generated an S1P that was resistant to PF-429242 in biochemical and cell culture assays. Our findings reveal selectivity in the recognition of substrates by S1P and provide a roadmap for the rational design of improved S1P inhibitors.Keywords
Funding Information
- HHS | NIH | National Institute of General Medical Sciences (R00GM141261)
- HHS | NIH | National Institute of General Medical Sciences (R01GM155152)
- Dutch Heart Foundation (2013T111)
- Netherlands Organization for Scientific Research (016.176.643)
- Netherlands Organization for Scientific Research (M.22.034; GENESIS)
This publication has 42 references indexed in Scilit:
- Site-1 and site-2 proteases: A team of two in regulated proteolysisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturationProtein & Cell, 2020
- Site-1 protease, a novel metabolic target for glioblastomaBiochemical and Biophysical Research Communications, 2017
- Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferationBiochemical and Biophysical Research Communications, 2017
- Roles of regulated intramembrane proteolysis in virus infection and antiviral immunityBiochimica et Biophysica Acta (BBA) - Biomembranes, 2013
- Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242Virology, 2012
- Arenavirus envelope glycoproteins mimic autoprocessing sites of the cellular proprotein convertase subtilisin kexin isozyme-1/site-1 proteaseVirology, 2011
- Aminopyrrolidineamide inhibitors of site-1 proteaseBioorganic & Medicinal Chemistry Letters, 2007
- The crystal structure of an autoprocessed Ser221Cys-subtilisin E-propeptide complex at 2.0 å resolution 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1998
- Sterol-Regulated Release of SREBP-2 from Cell Membranes Requires Two Sequential Cleavages, One Within a Transmembrane SegmentCell, 1996